APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 100 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,515,000 | -47.3% | 106,632 | +1.0% | 0.03% | -42.4% |
| Q2 2021 | $6,675,000 | +13.5% | 105,624 | -22.9% | 0.06% | +3.5% |
| Q1 2021 | $5,879,000 | -24.8% | 137,019 | +0.3% | 0.06% | -35.2% |
| Q4 2020 | $7,817,000 | +168.7% | 136,654 | +41.7% | 0.09% | +104.7% |
| Q3 2020 | $2,909,000 | -13.5% | 96,415 | -6.4% | 0.04% | -4.4% |
| Q2 2020 | $3,364,000 | -6.0% | 103,013 | -22.8% | 0.04% | -18.2% |
| Q1 2020 | $3,577,000 | -9.2% | 133,518 | +3.7% | 0.06% | +77.4% |
| Q4 2019 | $3,941,000 | +28.7% | 128,696 | +1.3% | 0.03% | +29.2% |
| Q3 2019 | $3,061,000 | -8.7% | 127,056 | -4.0% | 0.02% | -4.0% |
| Q2 2019 | $3,354,000 | +26.6% | 132,351 | -2.6% | 0.02% | +31.6% |
| Q1 2019 | $2,649,000 | +54.6% | 135,848 | +4.5% | 0.02% | +46.2% |
| Q4 2018 | $1,714,000 | -3.1% | 129,973 | +30.7% | 0.01% | +8.3% |
| Q3 2018 | $1,768,000 | -1.0% | 99,413 | +22.5% | 0.01% | 0.0% |
| Q2 2018 | $1,786,000 | – | 81,182 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 624,962 | $20,599,000 | 13.29% |
| Octagon Capital Advisors LP | 1,595,911 | $52,601,000 | 12.95% |
| Logos Global Management LP | 1,450,000 | $47,792,000 | 3.45% |
| Avoro Capital Advisors LLC | 5,000,000 | $164,800,000 | 2.59% |
| Ghost Tree Capital, LLC | 200,000 | $6,592,000 | 1.93% |
| Integral Health Asset Management, LLC | 190,000 | $6,262,000 | 1.80% |
| GREAT POINT PARTNERS LLC | 200,000 | $6,592,000 | 1.54% |
| Aufman Associates Inc | 53,642 | $1,768,000 | 1.45% |
| Ghost Tree Capital, LLC | 150,000 | $4,944,000 | 1.45% |
| Altium Capital Management LP | 166,700 | $5,494,000 | 1.44% |